Controversial Alzheimer’s drug accounts for half of Medicare B premium hike – New York Post
A controversial new Alzheimer’s drug is driving one of the largest increases in Medicare “Part B” premiums. The standard outpatient premium for the senior healthcare program will leap by $21.60 a mo… [+1738 zCode System Review]